A detailed history of Invesco Ltd. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Invesco Ltd. holds 3,203,293 shares of BLFS stock, worth $87.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,203,293
Previous 3,320,131 3.52%
Holding current value
$87.4 Million
Previous $71.2 Million 12.69%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$19.19 - $26.52 $2.24 Million - $3.1 Million
-116,838 Reduced 3.52%
3,203,293 $80.2 Million
Q2 2024

Aug 13, 2024

BUY
$15.14 - $22.99 $31 Million - $47 Million
2,044,714 Added 160.32%
3,320,131 $71.2 Million
Q1 2024

May 14, 2024

BUY
$15.35 - $18.82 $1.41 Million - $1.73 Million
91,858 Added 7.76%
1,275,417 $23.7 Million
Q4 2023

Feb 12, 2024

BUY
$8.99 - $16.86 $1.18 Million - $2.22 Million
131,494 Added 12.5%
1,183,559 $19.2 Million
Q3 2023

Nov 13, 2023

BUY
$10.81 - $22.96 $696,974 - $1.48 Million
64,475 Added 6.53%
1,052,065 $14.5 Million
Q2 2023

Aug 11, 2023

BUY
$17.19 - $24.34 $3.09 Million - $4.38 Million
179,950 Added 22.28%
987,590 $21.8 Million
Q1 2023

May 12, 2023

BUY
$17.67 - $26.07 $149,912 - $221,177
8,484 Added 1.06%
807,640 $17.6 Million
Q4 2022

Feb 13, 2023

BUY
$16.95 - $25.07 $449,988 - $665,558
26,548 Added 3.44%
799,156 $14.5 Million
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $244,297 - $445,542
16,687 Added 2.21%
772,608 $17.6 Million
Q2 2022

Aug 15, 2022

SELL
$10.54 - $24.2 $48,146 - $110,545
-4,568 Reduced 0.6%
755,921 $10.4 Million
Q1 2022

May 16, 2022

SELL
$20.81 - $37.29 $192,430 - $344,820
-9,247 Reduced 1.2%
760,489 $17.3 Million
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $5.38 Million - $9.55 Million
163,176 Added 26.9%
769,736 $28.7 Million
Q3 2021

Nov 15, 2021

BUY
$42.03 - $60.5 $4.71 Million - $6.78 Million
112,099 Added 22.67%
606,560 $25.7 Million
Q2 2021

Aug 17, 2021

BUY
$29.51 - $44.62 $2.21 Million - $3.34 Million
74,816 Added 17.83%
494,461 $22 Million
Q1 2021

May 17, 2021

BUY
$32.95 - $44.24 $9.19 Million - $12.3 Million
278,914 Added 198.19%
419,645 $15.1 Million
Q4 2020

Feb 16, 2021

SELL
$27.5 - $45.75 $310,200 - $516,060
-11,280 Reduced 7.42%
140,731 $5.61 Million
Q3 2020

Nov 16, 2020

BUY
$16.04 - $28.94 $2.44 Million - $4.4 Million
152,011 New
152,011 $4.4 Million
Q4 2019

Feb 14, 2020

SELL
$14.59 - $18.9 $150,831 - $195,388
-10,338 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$15.7 - $20.98 $1.11 Million - $1.49 Million
-70,981 Reduced 87.29%
10,338 $172,000
Q2 2019

Aug 14, 2019

BUY
$15.2 - $19.42 $55,768 - $71,251
3,669 Added 4.73%
81,319 $1.38 Million
Q1 2019

May 15, 2019

BUY
$10.9 - $21.26 $564,412 - $1.1 Million
51,781 Added 200.17%
77,650 $1.39 Million
Q4 2018

Feb 14, 2019

BUY
$9.5 - $17.17 $245,755 - $444,170
25,869 New
25,869 $311,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.16B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.